The Motley Fool Discussion Boards

Previous Page

Stocks I / Immunomedics, Inc.


Subject:  Re: New to the game Date:  2/26/2000  12:12 PM
Author:  tholsing Number:  26 of 89


Well said. I am a long term holder of this company as well and have the same opinion that this technology is in its infancy. It is speculation that the FDA support will occur, but a risk worth taking. What is the current competetion for IMMU? About 1/2 of my portfolio consists of biotech companies in their infancy. This has been rewarding recently--but only due to the recent interest in these stocks. Once again, thanks for the informative post.

Copyright 1996-2020 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us